Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

3'-modified oligonucleotides and their conjugates.

Lyttle MH.

Curr Protoc Nucleic Acid Chem. 2001 May;Chapter 4:Unit 4.6. doi: 10.1002/0471142700.nc0406s03.

PMID:
18428853
2.

Evaluation of new linkers and synthetic methods for internal modified oligonucleotides.

Walton TA, Lyttle MH, Dick DJ, Cook RM.

Bioconjug Chem. 2002 Sep-Oct;13(5):1155-8.

PMID:
12236799
3.

New reagents and methods for the synthesis of internal and 3'-labeled DNA.

Lyttle MH, Walton TA, Dick DJ, Carter TG, Beckman JH, Cook RM.

Bioconjug Chem. 2002 Sep-Oct;13(5):1146-54.

PMID:
12236798
4.

A tetramethyl rhodamine (Tamra) phosphoramidite facilitates solid-phase-supported synthesis of 5'-Tamra DNA.

Lyttle MH, Carter TG, Dick DJ, Cook RM.

J Org Chem. 2000 Dec 29;65(26):9033-8.

PMID:
11149848
5.

A phosphate bound universal linker for DNA synthesis.

Lyttle MH, Dick DJ, Hudson D, Cook RM.

Nucleosides Nucleotides. 1999 Aug;18(8):1809-24.

PMID:
10478485
6.

Versatile linker chemistry for synthesis of 3'-modified DNA.

Lyttle MH, Adams H, Hudson D, Cook RM.

Bioconjug Chem. 1997 Mar-Apr;8(2):193-8.

PMID:
9095360
7.

A new universal linker for solid phase DNA synthesis.

Lyttle MH, Hudson D, Cook RM.

Nucleic Acids Res. 1996 Jul 15;24(14):2793-8.

8.

Design, synthesis, and evaluation of latent alkylating agents activated by glutathione S-transferase.

Satyam A, Hocker MD, Kane-Maguire KA, Morgan AS, Villar HO, Lyttle MH.

J Med Chem. 1996 Apr 12;39(8):1736-47.

PMID:
8648613
9.

Salt-induced immobilizations of DNA oligonucleotides on an epoxide-activated high-performance liquid chromatographic affinity support.

Wheatley JB, Lyttle MH, Hocker MD, Schmidt DE Jr.

J Chromatogr A. 1996 Mar 1;726(1-2):77-90.

PMID:
8900520
10.

p-Nitrobenzyl side-chain protection for solid-phase synthesis.

Hocker MD, Caldwell CG, Macsata RW, Lyttle MH.

Pept Res. 1995 Nov-Dec;8(6):310-15.

PMID:
8838413
11.

Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors.

Ciaccio PJ, Shen H, Jaiswal AK, Lyttle MH, Tew KD.

Mol Pharmacol. 1995 Oct;48(4):639-47.

PMID:
7476889
12.

Mutagenesis using trinucleotide beta-cyanoethyl phosphoramidites.

Lyttle MH, Napolitano EW, Calio BL, Kauvar LM.

Biotechniques. 1995 Aug;19(2):274-81.

PMID:
8527149
13.

Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding.

Walter AE, Turner DH, Kim J, Lyttle MH, Müller P, Mathews DH, Zuker M.

Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9218-22.

14.

Glutathione-S-transferase activates novel alkylating agents.

Lyttle MH, Satyam A, Hocker MD, Bauer KE, Caldwell CG, Hui HC, Morgan AS, Mergia A, Kauvar LM.

J Med Chem. 1994 May 13;37(10):1501-7.

PMID:
8182709
15.

Isozyme-specific glutathione-S-transferase inhibitors: design and synthesis.

Lyttle MH, Hocker MD, Hui HC, Caldwell CG, Aaron DT, Engqvist-Goldstein A, Flatgaard JE, Bauer KE.

J Med Chem. 1994 Jan 7;37(1):189-94.

PMID:
8289195
16.

RNA hairpin loop stability depends on closing base pair.

Serra MJ, Lyttle MH, Axenson TJ, Schadt CA, Turner DH.

Nucleic Acids Res. 1993 Aug 11;21(16):3845-9.

17.

Construction of affinity sorbents utilizing glutathione analogs.

Lyttle MH, Aaron DT, Hocker MD, Hughes BR.

Pept Res. 1992 Nov-Dec;5(6):336-42.

PMID:
1493361
18.

Site-specific incorporation of nonnatural residues during in vitro protein biosynthesis with semisynthetic aminoacyl-tRNAs.

Bain JD, Diala ES, Glabe CG, Wacker DA, Lyttle MH, Dix TA, Chamberlin AR.

Biochemistry. 1991 Jun 4;30(22):5411-21.

PMID:
2036409

Supplemental Content

Loading ...
Support Center